HAE
Price
$75.20
Change
+$0.94 (+1.27%)
Updated
Jul 25 closing price
Capitalization
4.33B
10 days until earnings call
SRTS
Price
$5.65
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
61.97M
10 days until earnings call
Interact to see
Advertisement

HAE vs SRTS

Header iconHAE vs SRTS Comparison
Open Charts HAE vs SRTSBanner chart's image
Haemonetics
Price$75.20
Change+$0.94 (+1.27%)
Volume$315.96K
Capitalization4.33B
Sensus Healthcare
Price$5.65
Change-$0.00 (-0.00%)
Volume$848
Capitalization61.97M
HAE vs SRTS Comparison Chart in %
Loading...
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HAE vs. SRTS commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAE is a Hold and SRTS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (HAE: $75.20 vs. SRTS: $5.65)
Brand notoriety: HAE and SRTS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HAE: 58% vs. SRTS: 1%
Market capitalization -- HAE: $4.33B vs. SRTS: $61.97M
HAE [@Medical Specialties] is valued at $4.33B. SRTS’s [@Medical Specialties] market capitalization is $61.97M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HAE’s FA Score shows that 0 FA rating(s) are green whileSRTS’s FA Score has 1 green FA rating(s).

  • HAE’s FA Score: 0 green, 5 red.
  • SRTS’s FA Score: 1 green, 4 red.
According to our system of comparison, SRTS is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HAE’s TA Score shows that 5 TA indicator(s) are bullish while SRTS’s TA Score has 4 bullish TA indicator(s).

  • HAE’s TA Score: 5 bullish, 4 bearish.
  • SRTS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, HAE is a better buy in the short-term than SRTS.

Price Growth

HAE (@Medical Specialties) experienced а +3.65% price change this week, while SRTS (@Medical Specialties) price change was +30.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

HAE is expected to report earnings on Aug 07, 2025.

SRTS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HAE($4.34B) has a higher market cap than SRTS($62M). SRTS has higher P/E ratio than HAE: SRTS (126.00) vs HAE (34.47). HAE YTD gains are higher at: -3.689 vs. SRTS (-18.353). HAE has higher annual earnings (EBITDA): 264M vs. SRTS (79K). HAE has more cash in the bank: 194M vs. SRTS (23.1M). SRTS has less debt than HAE: SRTS (783K) vs HAE (871M). HAE has higher revenues than SRTS: HAE (1.27B) vs SRTS (24.4M).
HAESRTSHAE / SRTS
Capitalization4.34B62M6,992%
EBITDA264M79K334,177%
Gain YTD-3.689-18.35320%
P/E Ratio34.47126.0027%
Revenue1.27B24.4M5,205%
Total Cash194M23.1M840%
Total Debt871M783K111,239%
FUNDAMENTALS RATINGS
HAE vs SRTS: Fundamental Ratings
HAE
SRTS
OUTLOOK RATING
1..100
7533
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10082
SMR RATING
1..100
4786
PRICE GROWTH RATING
1..100
5349
P/E GROWTH RATING
1..100
928
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HAE's Valuation (72) in the Medical Specialties industry is in the same range as SRTS (72). This means that HAE’s stock grew similarly to SRTS’s over the last 12 months.

SRTS's Profit vs Risk Rating (82) in the Medical Specialties industry is in the same range as HAE (100). This means that SRTS’s stock grew similarly to HAE’s over the last 12 months.

HAE's SMR Rating (47) in the Medical Specialties industry is somewhat better than the same rating for SRTS (86). This means that HAE’s stock grew somewhat faster than SRTS’s over the last 12 months.

SRTS's Price Growth Rating (49) in the Medical Specialties industry is in the same range as HAE (53). This means that SRTS’s stock grew similarly to HAE’s over the last 12 months.

SRTS's P/E Growth Rating (8) in the Medical Specialties industry is significantly better than the same rating for HAE (92). This means that SRTS’s stock grew significantly faster than HAE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HAESRTS
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
68%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
62%
Bearish Trend 17 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAORF2.20N/A
N/A
Mandarin Oriental International Ltd.
VLXC0.09N/A
N/A
Veltex Corp.
ANKM12.00N/A
N/A
ANKAM INC.
AHKSY13.95-0.14
-0.99%
Asahi Kaisei Corp.
HKTVY4.22-0.88
-17.25%
Hong Kong Technology Venture Company Ltd

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with CNMD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then CNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+1.27%
CNMD - HAE
42%
Loosely correlated
+2.80%
ATR - HAE
41%
Loosely correlated
-0.51%
OM - HAE
39%
Loosely correlated
+5.22%
GH - HAE
38%
Loosely correlated
-2.35%
CERS - HAE
38%
Loosely correlated
+2.21%
More

SRTS and

Correlation & Price change

A.I.dvisor tells us that SRTS and HAE have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRTS and HAE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
N/A
HAE - SRTS
28%
Poorly correlated
+1.27%
BFLY - SRTS
28%
Poorly correlated
-5.29%
MYO - SRTS
27%
Poorly correlated
-2.31%
HOLX - SRTS
26%
Poorly correlated
+0.61%
MTD - SRTS
26%
Poorly correlated
+0.26%
More